中国现代医生Issue(11)：128-131,4.
复方养血汤治疗癌性贫血的临床疗效观察
Clinical efficacy of Fufang Yangxue Tang for cancer-related anemia
摘要
Abstract
Objective To discuss clinical efficacy of Fufang Yangxue Tang for cancer-related anemia. Methods Clini-cal data of 120 cases with cancer-related anemia were respectively analyzed. 64 cases of control group were treated by EPO, and 56 cases of study group were treated by Fufang Yangxue Tang based on treatment of EPO. Clinical efficacy of two groups was compared. Results After treatment of 8 weeks, efficiency of study group was 67.9%, and performance status improvement rate was 82.1%, which were higher than control group (P<0.05);Hb and Hct levels after treatment of 4 weeks and 8 weeks increased compared with before treatment(P<0.01), and study group improved more(P<0.01). Conclusion Fufang Yangxue Tang combined with EPO in treatment of cancer-related anemia can improve clinical effi-cacy, improve performance status and Hb and Hct, worthy of clinical promotion.关键词
复方养血汤/癌性贫血/促红细胞生成素Key words
Fufang Yangxue Tang/Cancer-related anemia/EPO分类
医药卫生引用本文复制引用
胡文雷,何煜舟..复方养血汤治疗癌性贫血的临床疗效观察[J].中国现代医生,2015,(11):128-131,4.基金项目
浙江省中医药科技计划 （）
